#Japan #Johnson & Johnson #Tokyo #Lung Cancer #Value of Time

Johnson & Johnson's Value of Time Campaign

Johnson & Johnson (J&J), known in Japan as Janssen Pharmaceutical K.K., has launched the second phase of its "Value of Time" campaign, revealing new research insights from the perspective of lung cancer patients. The campaign aims to remind patients of the invaluable moments they share with loved ones, even while facing a serious diagnosis.

In July, a survey was conducted involving 188 patients diagnosed with stage IIIB to IV lung cancer or those experiencing postoperative recurrence, who are undergoing drug therapy. The survey results demonstrated that a staggering 90% of lung cancer patients prioritize treatments that extend their survival with effectiveness as a critical component.

Key Findings from the Survey

1. Prioritization of Treatment Options:
- Among the patients, 45% expressed a strong desire to receive treatments they believe will effectively extend their survival. Furthermore, 40% valued spending as much time as possible with family and loved ones in the decision-making process about their initial treatment options.
- This indicates that a focus on effective treatments and quality family time drives patients' perspectives when facing their cancer journey.

2. Current Values and Experiences:
- The survey also explored patients' current values, with 52% expressing it’s very important to spend time with loved ones and maintain hope during their cancer journey. Altogether, 94% rated the importance of spending valuable time with family as high.
- These insights underscore the emotional landscape of patients, emphasizing that being with family is paramount throughout their treatment.

3. Desires for Initial Treatment:
- Patients indicated they wish for cancer to not progress for 27% of respondents, while the same percentage desired an extension of their overall survival time. Another 20% indicated a request to continue living as normally as possible.

4. Satisfaction through Shared Decision Making:
- The study assessed the impact of Shared Decision Making (SDM) on treatment satisfaction. The results show that patients who engaged in SDM scored significantly higher in satisfaction—8.4 out of 10—compared to those who had little SDM involvement, who averaged 6.1.
- This advocates for the importance of transparent communication between patients and healthcare providers when selecting treatment options.

Importance of Communication

The findings have been confirmed by Kazuo Hasegawa, chairperson of the non-profit organization One Step for lung cancer patients, who stated, "The time spent with family and loved ones is essential. Alongside the desire to live longer, how we utilize that precious time is equally important. If patients convey their profound thoughts and values to their healthcare providers, it can lead to a more satisfying treatment choice."

The Importance of the Value of Time Campaign

The campaign revolves around the belief that personalized and innovative treatments can bring hope to lung cancer patients. A video released alongside the findings encourages patients to reflect on what matters most to them, capturing timeless moments and family interactions. The video emphasizes the value of communicating with physicians about treatment options to extend time with loved ones.

The broader initiative includes plans to introduce interviews with patients and specialists, aiming to build ongoing support for those diagnosed with lung cancer, ensuring they do not walk this challenging path alone.

Looking Ahead: J&J Commitment

As part of its Value of Time campaign's vision, J&J remains dedicated to fostering open dialogues in patients' treatment journeys and providing essential information on treatment options and SDM. The overarching commitment is to honor patients' time and to empower them with the knowledge needed to take an active role in their care.

For more information on the Value of Time campaign, visit the official site: Value of Time.

This effort underlines not just the need for innovative medicine but also the importance of emotional well-being and hope for patients and their families during what is often a profoundly challenging period.

Conclusion

In conclusion, the Value of Time campaign not only addresses the medical needs of lung cancer patients but significantly enhances understanding of their emotional wishes and values. By shining a light on the patient experience, J&J invites everyone involved in the healthcare process to prioritize what truly matters: the time spent with loved ones. Together, we can make a difference in the fight against lung cancer.